Skip to content
Home » Explore » Okayama University Analysis of the infection situation and medical provision system in Okayama Prefecture (as of September 6, 2024)

Okayama University Analysis of the infection situation and medical provision system in Okayama Prefecture (as of September 6, 2024)

National University Corporation Okayama University
[Okayama University] Analysis of the infection situation and medical provision system in Okayama Prefecture (as of September 6, 2024) ……
September 8, 2024 (Reiwa 6) National University Corporation Okayama University https://www.okayama-u.ac.jp/


[Image 1

◆Summary We have compiled data (*) on the number of reported cases and the medical care delivery system published on the Okayama Prefecture website, and added comments by Okayama Prefecture expert volunteers. We plan to update once a week.
In addition, it is expressed in an easy-to-understand manner with reference to the Tokyo Metropolitan Government’s “Analysis and general comments on the latest monitoring items.” We hope this will be helpful in understanding the situation in the prefecture. The pandemic of the new coronavirus infection (COVID-19) has been declared over by the WHO, and normal life is returning to normal in our country. We continue to provide information in the hope that it will be helpful for infection prevention measures in daily life. Thank you for your support. *After transition to Category 5, the number of reported patients per sentinel is used.
◆Analysis of infection status and medical care delivery system [as of Friday, September 6, 2024]
Level 2. Infection is decreasing, but caution is needed
[Last time (Friday, August 30, 2024): Level 2. Infection is
decreasing, but caution is required]
The number of patients reported per sentinel has decreased slightly to 7.19. Cases of hand-foot-and-mouth disease and group A beta-hemolytic streptococcal pharyngitis are also decreasing. Movement and gatherings of people have calmed down for the time being, and the number of infected people is on the decline both nationwide and in Okayama. However, the characteristic of the virus remains that elderly people are more likely to become seriously ill. Proper use of masks and proper ventilation are required depending on the situation. Efforts must be made to avoid infecting those at high risk.
The number of hospitalized patients remains unchanged. High-risk patients require early diagnosis and early treatment.
[Image 2

https://www.unit-gp.jp/eisei/wp/wp-content/uploads/2020/12/感染状況 ・医療提供体制の 析_20240906.pdf
– Regarding the level evaluation of infection status and medical care provision system –
[Image 3

https://www.unit-gp.jp/eisei/wp/wp-content/uploads/2020/12/感染状況 ・医療提供体制の 析_5段階_20230520改訂.pdf ◆Okayama prefecture expert volunteer
Takashi Raito (Department of Epidemiology and Hygiene, Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama
University), Hidehiro Hagiya (Department of General Internal Medicine and General Practice, Okayama University Hospital), Koji Fujita (Department of General Internal Medicine and Infectious Diseases, Tsuyama Central Hospital), Yasunori Ichimura (National International Medical Research Center, International Medical Cooperation Bureau) Daisuke Yoshioka (Kawasaki Medical University, Clinical Infectious Diseases, Kawasaki Medical University Hospital, Infection Control Department)
(in no particular order)
[Image 5

http://www.unit-gp.jp/eisei/wp/?p=4631 – New
coronavirus vaccine information http:
// Okayama University’s response to the new coronavirus infection
https://www.okayama-u.ac.jp/tp/profile/aboutcoronavirus .html・Okayama University Hospital https://www.okayama-u.ac.jp/user/hospital/・Okayama University Hospital Corona Aftercare Outpatient Clinic
https://www.okayama-u.ac.jp/user/hospital /index377.html・[Okayama University] A large emergency transport vehicle “Doctor Car” that can carry ECMO has been deployed at Okayama University Hospital
6] Cooperating with WHO: Dispatch Dr. Hidehiro Hagiya to Papua New Guinea as a new coronavirus infectious disease control expert 7] New coronavirus special page (Follow-up 15) available to the public for a limited time
8] New coronavirus special feature Page (follow-up report 16) will be available to the public for a limited time ・[Okayama University x Dental Diamond Co.] New coronavirus special page (follow-up report 17) will be available for a limited time Available to the public for a limited time
10] New coronavirus special page (follow-up report 18) is available to the public for a limited time https:/ / 11] New coronavirus special page (Follow-up 19) is open to the public for a limited time
html/rd/p/000000347.000072793.html・[Okayama University x Dental Diamond Inc.] New coronavirus special page (follow-up report 20) is available to the public for a limited time .html・[Okayama University x Dental Diamond Inc.] New coronavirus special page (follow-up report 21) available to the public for a limited time 14] New coronavirus special page (Follow-up 22) available to the public for a limited time
15] New coronavirus Special feature page (follow-up report 23) is available to the public for a limited time 16] New coronavirus special page (follow-up report 24) Open to the public for a limited time
17] New coronavirus special page (follow-up report 25) is open to the public for a limited time https: // 18] New coronavirus special page (Follow-up 26) is open to the public for a limited time
/html/rd/p/000000921.000072793.html・[Okayama University x Dental Diamond Inc.] New coronavirus special page (follow-up report 27) is available to the public for a limited time [Okayama University x Dental Diamond Co.] New coronavirus special page (Follow-up 29) available to the public for a limited time
21] New coronavirus Virus special page (follow-up report 30) is open to the public for a limited time 22] New coronavirus special page (follow-up report 31) is available to the public for a limited time ・[Okayama University x Dental Diamond Inc.] New coronavirus special page (follow-up report 32) is available to the public for a limited time
// 24] New coronavirus special page (follow-up report 33) is open to the public for a limited time main/html/rd/p/000001491.000072793.html・[Okayama University x Dental Diamond Inc.] New coronavirus special page (follow-up report 35) is available to the public for a limited time /000001575.000072793.html・[Okayama University] School of Medicine, School of Health Sciences, Citizen Lecture “Let’s learn more about coronavirus infections – Nursing, Radiology, Testing” Lecture recordings have started streaming rd/p/000000815.000072793.html
◆Reference survey research report / [Okayama University] New coronavirus information “Interim report on investigation of adverse reactions after vaccination of children with new coronavirus” (Okayama University Department of Epidemiology and Hygiene vol. 1) published main/html/rd/p/000000687.000072793.html・[Okayama University] Novel coronavirus information “About the final report on the investigation of adverse reactions after vaccination of children with the new coronavirus” (Okayama University Epidemiology and Hygiene Department vol. 2) https:
// 29] New coronavirus information “About the effectiveness of vaccines to prevent infection and prevent aggravation in Okayama City” (Okayama University Department of Epidemiology and Hygiene vol. 3) Published 30] New coronavirus information “Final report on investigation of side effects after vaccination of infants with new coronavirus” (Okayama University Epidemiology・Hygiene field vol.4) Published ・[Okayama University] Investigation of side effects after vaccination of Takeda/Moderna COVID-19 vaccine [Final report] ~What are the results of the second vaccination aimed at the younger generation, which is half-male and half-male?~
33] Takeda/Moderna’s new model Follow-up survey report 1 month after vaccination against coronavirus ~Assessment of side effects and satisfaction level 1 month after vaccination~
34] Investigation of adverse reactions after additional vaccination (3rd vaccination) of Takeda/Moderna’s new coronavirus vaccine – Interim report –
35] Takeda / Surveillance of side effects after additional vaccination (3rd vaccination) of Moderna’s new coronavirus vaccine –
Final report – 36] Takeda/Moderna Report on the relationship between fever and antibody titer after additional vaccination (third vaccination) of the company’s new coronavirus vaccine
37] Aftereffects of the new coronavirus Does persistent infection within the host, which is thought to be the cause of the disease, occur? – Systemic infection and insufficient immune response are risk factors for persistent infection –
38] Approximately 10% of elderly facility residents have extremely weak immune responses despite vaccination, and measures are required 39] The rate of new asthma diagnoses in children has decreased during the coronavirus pandemic – Is it related to the decrease in respiratory virus infections due to infectious disease countermeasures?

・[Okayama University] Examining the characteristics of persistent side effects that occurred after vaccination with the new coronavirus vaccine
 
・Analysis of where people spend their final moments based on data from the Ministry of Health, Labor and Welfare – Place of death has shifted from hospitals to homes due to the coronavirus pandemic – [Okayama University, Iizuka Hospital]
 
・[Okayama University] Not all lingering symptoms after coronavirus infection are aftereffects ~ Based on internal diseases detected at the aftereffects of coronavirus outpatient clinic ~
 
・[Okayama University] Relationship between antibody titer and SARS-CoV-2 infection during the Omicron strain epidemic period  
・[Okayama University] Investigating the impact of prolonged symptoms due to the aftereffects of the new coronavirus on employment
・[Okayama University] Investigating the characteristics of
lightheadedness seen as a symptom of the aftereffects of the new coronavirus
 
・[Okayama University] Examination of prevention and treatment methods for the after-effects of the new coronavirus associated with persistent infection ~ Simultaneous combination of vaccines and antiviral drugs is expected to be effective in recovering symptoms ~  
[Image 6

[Image 7

http://www.unit-gp.jp/eisei/wp/-Okayama Regarding collaboration with university hospitals (for those involved in pharmaceutical and medical device companies) – Okayama University Hospital New Medical Research and Development Center 2-5-1 Shikata-cho, Kita-ku, Okayama City, Okayama Prefecture 700-8558 Please refer to the URL below. Please contact us regarding the project:
http://shin-iryo.hospital.okayama-u.ac.jp/ph_company/ – Regarding collaboration with Okayama University Hospital (for medical personnel and researchers) – Okayama University Hospital Research Promotion Division Industry-Academia-Government Collaboration Promotion 2-5-1 Shikata-cho, Kita-ku, Okayama-shi, Okayama 700-8558 TEL: 086-235-7983 E-mail: ouh-csnw◎adm.okayama-u.ac.jp http:
// – For inquiries regarding Okayama University’s industry-academia-government
collaboration, etc. – Okayama University Research and Innovation Co-Creation Organization Industry-Academia-Government Collaboration Headquarters Okayama, Okayama Prefecture, 700-8530 1-1-1 Tsushima Naka, Ichikita-ku Okayama University Tsushima Campus Main Building TEL: 086-251-8463 E-mail: sangaku◎okayama-u.ac.jp
https://www.orsd.okayama-u.ac. jp/
Okayama University Integrated Report 2023:

Okayama University SDGs homepage: https://sdgs.okayama-u.ac.jp/ Okayama University SDGs – Thinking about the sustainability of local communities (YouTube): https://youtu.be/Qdqjy4mw4ik Okayama University Image Movie (YouTube) ): https://youtu.be/pKMHm4XJLtw
[Image 9

[Image 10





This article was partly generated by AI. Some links may contain Ads. Press Release-Informed Article.